Cargando…

Deep Learning Prediction of Response to Anti-VEGF among Diabetic Macular Edema Patients: Treatment Response Analyzer System (TRAS)

Diabetic macular edema (DME) is the most common cause of visual impairment among patients with diabetes mellitus. Anti-vascular endothelial growth factors (Anti-VEGFs) are considered the first line in its management. The aim of this research has been to develop a deep learning (DL) model for predict...

Descripción completa

Detalles Bibliográficos
Autores principales: Alryalat, Saif Aldeen, Al-Antary, Mohammad, Arafa, Yasmine, Azad, Babak, Boldyreff, Cornelia, Ghnaimat, Tasneem, Al-Antary, Nada, Alfegi, Safa, Elfalah, Mutasem, Abu-Ameerh, Mohammed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870773/
https://www.ncbi.nlm.nih.gov/pubmed/35204404
http://dx.doi.org/10.3390/diagnostics12020312
_version_ 1784656838415876096
author Alryalat, Saif Aldeen
Al-Antary, Mohammad
Arafa, Yasmine
Azad, Babak
Boldyreff, Cornelia
Ghnaimat, Tasneem
Al-Antary, Nada
Alfegi, Safa
Elfalah, Mutasem
Abu-Ameerh, Mohammed
author_facet Alryalat, Saif Aldeen
Al-Antary, Mohammad
Arafa, Yasmine
Azad, Babak
Boldyreff, Cornelia
Ghnaimat, Tasneem
Al-Antary, Nada
Alfegi, Safa
Elfalah, Mutasem
Abu-Ameerh, Mohammed
author_sort Alryalat, Saif Aldeen
collection PubMed
description Diabetic macular edema (DME) is the most common cause of visual impairment among patients with diabetes mellitus. Anti-vascular endothelial growth factors (Anti-VEGFs) are considered the first line in its management. The aim of this research has been to develop a deep learning (DL) model for predicting response to intravitreal anti-VEGF injections among DME patients. The research included treatment naive DME patients who were treated with anti-VEGF. Patient’s pre-treatment and post-treatment clinical and macular optical coherence tomography (OCT) were assessed by retina specialists, who annotated pre-treatment images for five prognostic features. Patients were also classified based on their response to treatment in their post-treatment OCT into either good responder, defined as a reduction of thickness by >25% or 50 µm by 3 months, or poor responder. A novel modified U-net DL model for image segmentation, and another DL EfficientNet-B3 model for response classification were developed and implemented for predicting response to anti-VEGF injections among patients with DME. Finally, the classification DL model was compared with different levels of ophthalmology residents and specialists regarding response classification accuracy. The segmentation deep learning model resulted in segmentation accuracy of 95.9%, with a specificity of 98.9%, and a sensitivity of 87.9%. The classification accuracy of classifying patients’ images into good and poor responders reached 75%. Upon comparing the model’s performance with practicing ophthalmology residents, ophthalmologists and retina specialists, the model’s accuracy is comparable to ophthalmologist’s accuracy. The developed DL models can segment and predict response to anti-VEGF treatment among DME patients with comparable accuracy to general ophthalmologists. Further training on a larger dataset is nonetheless needed to yield more accurate response predictions.
format Online
Article
Text
id pubmed-8870773
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88707732022-02-25 Deep Learning Prediction of Response to Anti-VEGF among Diabetic Macular Edema Patients: Treatment Response Analyzer System (TRAS) Alryalat, Saif Aldeen Al-Antary, Mohammad Arafa, Yasmine Azad, Babak Boldyreff, Cornelia Ghnaimat, Tasneem Al-Antary, Nada Alfegi, Safa Elfalah, Mutasem Abu-Ameerh, Mohammed Diagnostics (Basel) Article Diabetic macular edema (DME) is the most common cause of visual impairment among patients with diabetes mellitus. Anti-vascular endothelial growth factors (Anti-VEGFs) are considered the first line in its management. The aim of this research has been to develop a deep learning (DL) model for predicting response to intravitreal anti-VEGF injections among DME patients. The research included treatment naive DME patients who were treated with anti-VEGF. Patient’s pre-treatment and post-treatment clinical and macular optical coherence tomography (OCT) were assessed by retina specialists, who annotated pre-treatment images for five prognostic features. Patients were also classified based on their response to treatment in their post-treatment OCT into either good responder, defined as a reduction of thickness by >25% or 50 µm by 3 months, or poor responder. A novel modified U-net DL model for image segmentation, and another DL EfficientNet-B3 model for response classification were developed and implemented for predicting response to anti-VEGF injections among patients with DME. Finally, the classification DL model was compared with different levels of ophthalmology residents and specialists regarding response classification accuracy. The segmentation deep learning model resulted in segmentation accuracy of 95.9%, with a specificity of 98.9%, and a sensitivity of 87.9%. The classification accuracy of classifying patients’ images into good and poor responders reached 75%. Upon comparing the model’s performance with practicing ophthalmology residents, ophthalmologists and retina specialists, the model’s accuracy is comparable to ophthalmologist’s accuracy. The developed DL models can segment and predict response to anti-VEGF treatment among DME patients with comparable accuracy to general ophthalmologists. Further training on a larger dataset is nonetheless needed to yield more accurate response predictions. MDPI 2022-01-26 /pmc/articles/PMC8870773/ /pubmed/35204404 http://dx.doi.org/10.3390/diagnostics12020312 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Alryalat, Saif Aldeen
Al-Antary, Mohammad
Arafa, Yasmine
Azad, Babak
Boldyreff, Cornelia
Ghnaimat, Tasneem
Al-Antary, Nada
Alfegi, Safa
Elfalah, Mutasem
Abu-Ameerh, Mohammed
Deep Learning Prediction of Response to Anti-VEGF among Diabetic Macular Edema Patients: Treatment Response Analyzer System (TRAS)
title Deep Learning Prediction of Response to Anti-VEGF among Diabetic Macular Edema Patients: Treatment Response Analyzer System (TRAS)
title_full Deep Learning Prediction of Response to Anti-VEGF among Diabetic Macular Edema Patients: Treatment Response Analyzer System (TRAS)
title_fullStr Deep Learning Prediction of Response to Anti-VEGF among Diabetic Macular Edema Patients: Treatment Response Analyzer System (TRAS)
title_full_unstemmed Deep Learning Prediction of Response to Anti-VEGF among Diabetic Macular Edema Patients: Treatment Response Analyzer System (TRAS)
title_short Deep Learning Prediction of Response to Anti-VEGF among Diabetic Macular Edema Patients: Treatment Response Analyzer System (TRAS)
title_sort deep learning prediction of response to anti-vegf among diabetic macular edema patients: treatment response analyzer system (tras)
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870773/
https://www.ncbi.nlm.nih.gov/pubmed/35204404
http://dx.doi.org/10.3390/diagnostics12020312
work_keys_str_mv AT alryalatsaifaldeen deeplearningpredictionofresponsetoantivegfamongdiabeticmacularedemapatientstreatmentresponseanalyzersystemtras
AT alantarymohammad deeplearningpredictionofresponsetoantivegfamongdiabeticmacularedemapatientstreatmentresponseanalyzersystemtras
AT arafayasmine deeplearningpredictionofresponsetoantivegfamongdiabeticmacularedemapatientstreatmentresponseanalyzersystemtras
AT azadbabak deeplearningpredictionofresponsetoantivegfamongdiabeticmacularedemapatientstreatmentresponseanalyzersystemtras
AT boldyreffcornelia deeplearningpredictionofresponsetoantivegfamongdiabeticmacularedemapatientstreatmentresponseanalyzersystemtras
AT ghnaimattasneem deeplearningpredictionofresponsetoantivegfamongdiabeticmacularedemapatientstreatmentresponseanalyzersystemtras
AT alantarynada deeplearningpredictionofresponsetoantivegfamongdiabeticmacularedemapatientstreatmentresponseanalyzersystemtras
AT alfegisafa deeplearningpredictionofresponsetoantivegfamongdiabeticmacularedemapatientstreatmentresponseanalyzersystemtras
AT elfalahmutasem deeplearningpredictionofresponsetoantivegfamongdiabeticmacularedemapatientstreatmentresponseanalyzersystemtras
AT abuameerhmohammed deeplearningpredictionofresponsetoantivegfamongdiabeticmacularedemapatientstreatmentresponseanalyzersystemtras